Drawing for INTELLIGENT MEDICINE

USPTO serial 77166849

INTELLIGENT MEDICINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROSSMAN, WILLIAM M
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INTELLIGENT MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christine B. Redfield and Susan E. Hollander

Christine B. Redfield and Susan E. Hollander K&L Gates LLP630 Hansen WayPalo Alto, CA 94304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Ingestible medicated and pharmaceutical compositions, namely, diagnostic and therapeutic preparations for medical purposes both prescription and over-the-counter, for use in connection with humans and animals, to gather data on patient status and condition, to monitor patient condition, patient adherence to treatment regimens, efficacy of treatment, and to enable personalized therapy for the purpose of maximizing patient outcome in the diagnosis, therapeutic treatment, and management of cancers, chronic pain, skin disease, diseases of the ear, nose, and throat, infectious disease, psychiatric disorders, and diseases of the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systemsACTIVE—
009Data central processing units for processing pharmaceutical or device compliance data, pharmaceutical administration data, device activation data or physiological response data; database computer software for use with medical devices for monitoring administration of pharmaceutical compositions, device activation or physiological responsesACTIVE—
010Conductance control devices for use with medical devices for use in administration of pharmaceutical compositions, namely, syringes, catheters, IV bags, infusion pumps for use with IV bags, implantable and topical fluid delivery ports, dialysis machines, inhalers, nebulizers for respiration therapy; medical monitoring devices for use in the administration of pharmaceutical compositions and for use with medical devices in the nature of syringes, catheters, IV bags, infusion pumps for use with IV bags, implantable and topical fluid delivery ports, dialysis machines, inhalers, nebulizers for respiration therapy; implantable electrical stimulation devices, namely, pacemakers, implantable cardioverter-defibrillators; transcutaneous and implantable electrotherapy devices, namely, neurological electrostimulation devices, musculoskeletal electrostimulation devices, respiratory electrostimulation devices, gastro-intestinal electrostimulation devices and electrical stimulation devices for use in stimulating the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systems; implantable physiological medical monitoring devices, namely, heart, gastro-intestinal, respiratory and neurological monitoring devicesACTIVE—
041Training and teaching in the field of prevention, diagnosis and treatment of medical conditionsACTIVE—
042Technical consultancy in the field of the design and development of medical devices and surgical equipment; medical research in the field of medical and surgical apparatus, appliances, instruments, therapies and drugs; medical and scientific research in the field of clinical trial services; computer software design for others, computer programming for others, and updating of computer software; maintenance of computer software; Providing medical and scientific research online information regarding pharmaceutical preparations for treatment of various diseasesACTIVE—
044Medical consultation and professional medical consultation in the field of medical and surgical equipment, apparatus, appliances and instruments, medical care, medical therapy and surgery; providing health and medical information about medical disorders; information services, namely, providing medical information to chronically ill patients; information services relating to medical services via a global computer network, namely, providing medical consultancy and advisory services via a global computer network; Providing online medical information regarding diagnostic properties of pharmaceutical preparations and medical devices for treatment of various diseasesACTIVE—
045Providing personal support services for patients, clinicians and families of patients with disorders relating to the treatment of medical disorders, namely, companionship, help with medical forms, counseling and emotional supportACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 28, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 28, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 10, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 30, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 7, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 1, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 1, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 1, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 1, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 22, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2010RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 26, 2009RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 26, 2009RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 28, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 27, 2009ALIEASSIGNED TO LIE—
Jan 22, 2009RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 24, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 19, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 19, 2008ALIEASSIGNED TO LIE—
Dec 19, 2007GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 19, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Dec 19, 2007CNSLSUSPENSION LETTER WRITTEN—
Dec 18, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 18, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2007CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2007DOCKASSIGNED TO EXAMINER—
May 1, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance